| # | Drug | Count |
|---|---|---|
| 0 | PORACTANT ALFA | 28 |
| 1 | ATAZANAVIR | 11 |
| 2 | RITONAVIR | 11 |
| 3 | RITONAVIR 100 MG | 11 |
| 4 | PROMETHAZINE HYDROCHLORIDE | 10 |
| 5 | VENLAFAXINE | 9 |
| 6 | VENLAFAXINE HYDROCHLORIDE | 9 |
| 7 | ESOMEPRAZOLE | 8 |
| 8 | LEVETIRACETAM | 8 |
| 9 | LEVETIRACETAM IN SODIUM CHLORIDE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PORACTANT ALFA | 28 | 0.0380 |
| 1 | I. V. FAT EMULSION | 1 | 0.0014 |
| 2 | NITRIC OXIDE | 5 | 0.0011 |
| 3 | DOPAMINE HYDROCHLORIDE | 4 | 0.0011 |
| 4 | MEPIVACAINE HYDROCHLORIDE | 1 | 0.0009 |
| 5 | CAFFEINE CITRATE | 2 | 0.0009 |
| 6 | DOBUTAMINE | 3 | 0.0008 |
| 7 | DOBUTAMINE HYDROCHLORIDE | 1 | 0.0008 |
| 8 | ATAZANAVIR | 11 | 0.0008 |
| 9 | RITONAVIR 100 MG | 11 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Surfactant [EPC] | 28 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 11 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 3 | Protease Inhibitor [EPC] | 11 |
| 4 | Catecholamine [EPC] | 6 |
| 5 | Mood Stabilizer [EPC] | 5 |
| 6 | Vasodilator [EPC] | 5 |
| 7 | Anti-epileptic Agent [EPC] | 4 |
| 8 | General Anesthetic [EPC] | 4 |
| 9 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Surfactant [EPC] | 28 | 0.0241 |
| 1 | Monobactam Antibacterial [EPC] | 2 | 0.0007 |
| 2 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 4 | 0.0005 |
| 3 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 4 | Vitamin K [EPC] | 3 | 0.0003 |
| 5 | Protease Inhibitor [EPC] | 11 | 0.0002 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 11 | 0.0002 |
| 7 | Prostaglandin E1 Analog [EPC] | 2 | 0.0001 |
| 8 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 2 | 0.0001 |
| 9 | General Anesthetic [EPC] | 4 | 0.0001 |